Pharmasset shareholder Millenco drops ownership to 4.9%

By Lisa Kerner

Charlotte, N.C., Dec. 18 - Investors led by Millenco LLC decreased their ownership interest in Pharmasset, Inc. to 4.9% from 6.2% through a series of sales between Oct. 29 and Dec. 17.

The investors beneficially own 1,147,823 shares of Pharmasset's outstanding stock, according to a schedule 13D/A filing with the Securities and Exchange Commission.

Pharmasset is a Princeton, N.J.-based clinical-stage pharmaceutical company focused on treatments for viral infections.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.